Dr. Rajeeve is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1275 York Avenue
New York, NY 10065- Is this information wrong?
Summary
- Physician-investigator with a clinical and research interest in plasma cell dyscrasias (Multiple Myeloma, Precursor states - MGUS/SMM, Amyloidosis, Waldenstrom's Macroglobulinemia, POEMS Syndrome etc.), cellular therapeutics, clinical trials, digital health technologies and healthcare delivery transformation.
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2020 - 2023- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2017 - 2020
Mahatma Gandhi UniversityClass of 2015, Bachelor of Medicine and Bachelor of Surgery (MBBS), Valedictorian
Certifications & Licensure
NY State Medical License Active through 2025
NJ State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Educational Commission for Foreign Medical GraduatesECFMG
Awards, Honors, & Recognition
- Domestic Scholar Award AIDS Malignancy Consortium
- Young Investigator Award (YIA) American Society of Clinical Oncology (ASCO), 2022
- HONORS Award and Grant American Society of Hematology (ASH)
Publications & Presentations
PubMed
- Unscheduled healthcare interactions in multiple myeloma patients receiving T cell redirection therapies.Anna J Howard, Isabel Concepcion, Alice X Wang, Issam S Hamadeh, Malin L Hultcrantz, Sham Mailankody, Carlyn Rose Tan, Neha Korde, Alexander M Lesokhin, Hani Hassoun, ...> ;Blood Advances. 2024 Apr 12
- Patterns of CRS with Teclistamab in Relapsed/Refractory Multiple Myeloma patients with Prior T-Cell Redirection Therapy.Issam S Hamadeh, Tala Shekarkhand, Colin Joseph Rueda, Ross S Firestone, Alice X Wang, Neha Korde, Malin L Hultcrantz, Alexander M Lesokhin, Sham Mailankody, Hani Hass...> ;Blood Advances. 2024 Apr 10
- 3 citationsHow Old is Too Old for CAR-T Cell Therapies in Multiple Myeloma?Sridevi Rajeeve, Saad Z Usmani> ;Transplantation and Cellular Therapy. 2023 Jun 1
- Join now to see all
Abstracts/Posters
- Etiologies and Predictors of 30-Day Readmission in Patients Undergoing Induction Chemotherapy for Acute Myeloid LeukemiaSridevi Rajeeve, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Myelodysplastic Syndromes: Trends in Mortality, Costs of Hospitalizations, Length of Stay and Rate of ComplicationsSridevi Rajeeve, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Acute Myeloid Leukemia and Cirrhosis: Trends in Utilization of Induction Chemotherapy, Rate of Hospitalizations and MortalitySridevi Rajeeve, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- European Hematology AssociationMember
Other Languages
- Hindi
Hospital Affiliations
Memorial Sloan Kettering Cancer CenterNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
